Feb 3 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2016 Dec 31, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.34 8.57 11.20
(-2.7 pct) (+5.1 pct) (+0.1 pct)
Operating 70 mln 221 mln 60 mln
(-68.0 pct) (-33.1 pct) (-27.9 pct)
Recurring 113 mln 280 mln 40 mln
(-59.7 pct) (-29.3 pct) (-68.0 pct)
Net 73 mln 168 mln 2 mln
(-56.3 pct) (-33.8 pct) (-90.2 pct)
EPS 2.12 yen 4.85 yen 0.06 yen
Ann Div 3.00 yen
-Q2 div NIL NIL
-Q4 div 3.00 yen
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T
((Tokyo Headline News Desk +813 6441 1812))